GEN3009
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN3009, covering 2024-08-13 to 2024-08-13. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas [Phase 1, Phase 2]